Insulin Aspart

Insulin aspart is a medication approved for treating type 1 and type 2 diabetes. It is a rapid-acting insulin that is injected 5 to 10 minutes before you start eating to help control the blood sugar spike that occurs after meals. Insulin aspart, which is available by prescription only, can also be given by IV or used in an insulin pump.

 

What Is Insulin Aspart?

Insulin aspart (NovoLog®) is a prescription form of insulin used to treat type 1 diabetes and type 2 diabetes. It is a rapid-acting insulin, used to help control the spike in blood sugar that occurs after meals. It is typically used in combination with a long-acting insulin. Insulin aspart can also be used in an insulin pump and can be given intravenously (by IV).
 
This article refers to plain insulin aspart. Insulin aspart is also available in combination with an intermediate-acting insulin (NovoLog Mix 70/30 or NovoLog Mix 50/50).
 
(Click What Is Insulin Aspart Used For? for more information, including possible off-label uses.)
 

Insulin Aspart Side Effects

As with any medicine, side effects are possible with insulin aspart. However, not everyone who uses the medication will experience side effects. In fact, most people tolerate it quite well. If side effects do occur, in most cases, they are minor and either require no treatment or can easily be treated by you or your healthcare provider. Serious side effects are less common.
 
Possible side effects of insulin aspart (as well as all other forms of insulin) include, but are not limited to:
 
  • Low blood sugar levels (hypoglycemia)
  • A skin reaction at the injection site
  • Thickening or pitting of the skin at the injection site.
     
(Click Side Effects of Insulin Aspart to learn more, including potentially serious side effects you should report immediately to your healthcare provider.)
 
(Insulin Aspart Continued: Page 2)
Add this article to your Favorites     Email this article     Print
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD;